Skip to main content
Clinical Trials/NCT04515992
NCT04515992
Completed
Not Applicable

Feasibility of Minimal Dose High Intensity Body-weight Circuit Training in Type 2 Diabetics

Kennesaw State University1 site in 1 country6 target enrollmentMarch 1, 2018
ConditionsType2 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type2 Diabetes
Sponsor
Kennesaw State University
Enrollment
6
Locations
1
Primary Endpoint
Change from baseline of HbA1c
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Exercise has been shown to be effective at improving fitness, as well as markers of glucose tolerance and control, in persons with type 2 diabetes. Recently, several investigations have demonstrated that improvements are realized by patients with high intensity interval exercise which is characterized by periods of vigorous exercise alternated by periods of moderate exercise. Typical interval training sessions require significantly less time to complete than traditional modes of exercise wherein moderate intensity activity is sustained for some time. This may be especially beneficial to those with type 2 diabetes, as lack of time is a frequently cited reason for not engaging in regular exercise. Bodyweight circuit training carries the potential to similarly improve health and metabolic function in persons with type 2 diabetes, and may do so with even a smaller accumulation of exercise because this type of exercise involves a greater percentage of the trainee's muscle mass compared with common forms of interval training (e.g., treadmill or cycle exercise). The purpose of this study is to quantify the effects of 3-4 sessions per week of bodyweight circuit training sustained for 5-10 minutes per session on health-related physical fitness and glucose tolerance/control in people with type 2 diabetes.

Registry
clinicaltrials.gov
Start Date
March 1, 2018
End Date
September 1, 2018
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Type 2 Diabetes of at least 1 year
  • hemoglobin A1c level between 6.0% and 10%

Exclusion Criteria

  • Currently engaging in a physical activity
  • Currently taking exogenous insulin
  • Undertaking a regiment or lifestyle modification intervention.
  • Cardiovascular or Pulmonary diseases.

Outcomes

Primary Outcomes

Change from baseline of HbA1c

Time Frame: 16 weeks

glycosylated hemoglobin, marker of approximate three month blood glucose environment

Study Sites (1)

Loading locations...

Similar Trials